Lataa...
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CL(pro)
The emerging SARS-CoV-2 infection is the cause of the global COVID-19 pandemic. To date, there are limited therapeutic options available to fight this disease. Here we examined the inhibitory abilities of two broad-spectrum antiviral natural products chebulagic acid (CHLA) and punicalagin (PUG) agai...
Tallennettuna:
| Julkaisussa: | Antiviral Res |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier B.V.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8052511/ https://ncbi.nlm.nih.gov/pubmed/33872675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2021.105075 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|